A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India

BackgroundThe medical management of DT comprises tyrosine kinase inhibitors (TKIs), hormonal agents, anti-inflammatory drugs with the recently approved gamma secretase inhibitor nirogacestat being the current standard of care. Real-world data on evolving treatment landscapes of DT remains scarce.Met...

Повний опис

Бібліографічні деталі

Автори:	Ghazal Tansir, Aparna Sharma, Bivas Biswas, Suryadev Narayan Sah, Somnath Roy, S. V. S. Deo, Sandeep Agarwala, Shah Alam Khan, Sameer Bakhshi, Deepam Pushpam
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-10-01
Серія:	Frontiers in Oncology
Предмети:	Desmoid tumor tyrosine kinase inhibitors oral metronomic therapy quality of life rare diseases
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1382856/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!